Cite
Expression of Benign and Malignant Thyroid Tissue in Ovarian Teratomas and the Importance of Multimodal Management as Illustrated by a BRAF-Positive Follicular Variant of Papillary Thyroid Cancer.
MLA
Erin F. Wolff, et al. “Expression of Benign and Malignant Thyroid Tissue in Ovarian Teratomas and the Importance of Multimodal Management as Illustrated by a BRAF-Positive Follicular Variant of Papillary Thyroid Cancer.” Thyroid, vol. 20, no. 9, Sept. 2010, pp. 981–87. EBSCOhost, https://doi.org/10.1089/thy.2009.0458.
APA
Erin F. Wolff, Marybeth Hughes, Maria J. Merino, James C. Reynolds, Jeremy L. Davis, Craig S. Cochran, & Francesco S. Celi. (2010). Expression of Benign and Malignant Thyroid Tissue in Ovarian Teratomas and the Importance of Multimodal Management as Illustrated by a BRAF-Positive Follicular Variant of Papillary Thyroid Cancer. Thyroid, 20(9), 981–987. https://doi.org/10.1089/thy.2009.0458
Chicago
Erin F. Wolff, Marybeth Hughes, Maria J. Merino, James C. Reynolds, Jeremy L. Davis, Craig S. Cochran, and Francesco S. Celi. 2010. “Expression of Benign and Malignant Thyroid Tissue in Ovarian Teratomas and the Importance of Multimodal Management as Illustrated by a BRAF-Positive Follicular Variant of Papillary Thyroid Cancer.” Thyroid 20 (9): 981–87. doi:10.1089/thy.2009.0458.